Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Kirsten Drejer
AddedMar 31, 2024
UpdatedMay 1, 2026
Kirsten Drejer

Kirsten Drejer

Board Member, Vækstfonden

Kirsten Drejer's Career

Vækstfonden
Vækstfonden

Hellerup, Capital Region of Denmark, DK

Board Member· Board
Malin
Malin

Dublin, County Dublin, IE

Board Member· Board
Zealand Pharma
Zealand Pharma

Copenhagen, Capital Region of Denmark, DK

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Kirsten Drejer's Career

Vækstfonden
Vækstfonden
Investment FirmInvestment Firm3481992Hellerup, Capital Region of Denmark, DK
Board Member· Board

Leadership at Vækstfonden

Tue MantoniTue MantoniBoard Member
Jacob Bratting PedersenJacob Bratting PedersenBoard Member
Jacob HübertzJacob HübertzCEO
Ulrik SporkUlrik SporkBoard Member
Anders ThoustrupAnders ThoustrupBoard Member
Carsten KochCarsten KochBoard Member
Malin
Malin
Public$50M52014Dublin, County Dublin, IE
Board Member· Board

Leadership at Malin

William DanielWilliam DanielBoard Member
Darragh LyonsDarragh LyonsBoard Member
Rudy MareelRudy MareelBoard Member
Liam DanielLiam DanielBoard Member
Sean MurphySean MurphyFounder
Zealand Pharma
Zealand Pharma
Public$1.9B2001998Copenhagen, Capital Region of Denmark, DK
Board Member· Board

Leadership at Zealand Pharma

Martin NicklassonMartin NicklassonBoard Member
Rémi DrollerRémi DrollerBoard Member
Eva SteinessEva SteinessCo-Founder
Jeff BerkowitzJeff BerkowitzBoard Member
Adam SteensbergAdam SteensbergCEO
Lars Hellerung ChristiansenLars Hellerung ChristiansenCo-Founder

Similar to Zealand Pharma

AstraZenecaAstraZenecaCambridge, Cambridgeshire, GBPharmaceuticalsest. 1999AstraZenecaCambridge, Cambridgeshire, GB · est. 1999

AstraZeneca PLC: A British-Swedish firm specializing in research, manufacturing, and sales of pharmaceuticals.

Public · $3.8B83.5k
LundbeckLundbeckCopenhagen, Capital Region of Denmark, DKPharmaceuticalsest. 1915LundbeckCopenhagen, Capital Region of Denmark, DK · est. 1915

Lundbeck A/S: A Danish pharmaceutical firm specializing in psychiatric and neurological treatments.

Public5.5k
LonzaLonzaBasel, Basel-Stadt, CHBiotech, Pharmaceuticalsest. 1897LonzaBasel, Basel-Stadt, CH · est. 1897

Swiss-based Lonza, a global partner in pharmaceuticals, biotech, and nutrition, develops and commercializes medical treatments worldwide.

Public · $400M17.5k
Zai LabZai LabShanghai, Shanghai, CNPharmaceuticalsest. 2014Zai LabShanghai, Shanghai, CN · est. 2014

Zai Lab, a Shanghai-based biopharmaceutical company, develops and manufactures treatments for oncology, autoimmune, and infectious diseases globally.

Public · $1.7B2k

Kirsten Drejer's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Kirsten Drejer

Thierry ChapusotThierry ChapusotBoard Member · PharmagestStephen ThompsonStephen ThompsonChairman at OncoRes MedicalThomas MeierThomas MeierBoard Member · VisgenxMarkus PedriksMarkus PedriksBoard Member · PharmajetTheresa TseTheresa TseBoard Member · Karolinska DevelopmentChris MirabelliChris MirabelliFounder · Ionis Pharmaceuticals